Auteurs
Curation
PubMed
Racine
Curation
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur la microsimulation - Curation (PubMed)

Index « Auteurs » - entrée « Marjolein Van Ballegooijen »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Marinus J C. Eijkemans < Marjolein Van Ballegooijen < Mark A. Boyd  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000089 (2012) Esther W. De Bekker-Grob [Pays-Bas] ; Inge M C M. De Kok ; Johan Bulten ; Joost Van Rosmalen ; Judith E M. Vedder ; Marc Arbyn ; Paul J J M. Klinkhamer ; Albertus G. Siebers ; Marjolein Van BallegooijenLiquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis.
000092 (2012) Iris Lansdorp-Vogelaar [Pays-Bas] ; Karen M. Kuntz ; Amy B. Knudsen ; Marjolein Van Ballegooijen ; Ann G. Zauber ; Ahmedin JemalContribution of screening and survival differences to racial disparities in colorectal cancer rates.
000094 (2013) S Lucas Goede [Pays-Bas] ; Aafke H C. Van Roon ; Jacqueline C I Y. Reijerink ; Anneke J. Van Vuuren ; Iris Lansdorp-Vogelaar ; J Dik F. Habbema ; Ernst J. Kuipers ; Monique E. Van Leerdam ; Marjolein Van BallegooijenCost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.
000100 (2012) Inge M C M. De Kok [Pays-Bas] ; Joost Van Rosmalen ; Joakim Dillner ; Marc Arbyn ; Peter Sasieni ; Thomas Iftner ; Marjolein Van BallegooijenPrimary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.
000120 (2011) Janneke A. Wilschut [Pays-Bas] ; J Dik F. Habbema ; Monique E. Van Leerdam ; Lieke Hol ; Iris Lansdorp-Vogelaar ; Ernst J. Kuipers ; Marjolein Van BallegooijenFecal occult blood testing when colonoscopy capacity is limited.
000131 (2011) Janneke A. Wilschut [Pays-Bas] ; Lieke Hol ; Evelien Dekker ; Jan B. Jansen ; Monique E. Van Leerdam ; Iris Lansdorp-Vogelaar ; Ernst J. Kuipers ; J Dik F. Habbema ; Marjolein Van BallegooijenCost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening.
000140 (2011) Marjolein Van Ballegooijen [Pays-Bas] ; Carolyn M. Rutter ; Amy B. Knudsen ; Ann G. Zauber ; James E. Savarino ; Iris Lansdorp-Vogelaar ; Rob Boer ; Eric J. Feuer ; J Dik F. Habbema ; Karen M. KuntzClarifying differences in natural history between models of screening: the case of colorectal cancer.
000141 (2011) Karen M. Kuntz [États-Unis] ; Iris Lansdorp-Vogelaar ; Carolyn M. Rutter ; Amy B. Knudsen ; Marjolein Van Ballegooijen ; James E. Savarino ; Eric J. Feuer ; Ann G. ZauberA systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression.
000143 (2011) James F. O'Mahony [Pays-Bas] ; Inge M C M. De Kok ; Joost Van Rosmalen ; J Dik F. Habbema ; Werner Brouwer ; Marjolein Van BallegooijenPractical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohorts.
000149 (2011) Amy Berrington De González [États-Unis] ; Kwang Pyo Kim ; Amy B. Knudsen ; Iris Lansdorp-Vogelaar ; Carolyn M. Rutter ; Rebecca Smith-Bindman ; Judy Yee ; Karen M. Kuntz ; Marjolein Van Ballegooijen ; Ann G. Zauber ; Christine D. BergRadiation-related cancer risks from CT colonography screening: a risk-benefit analysis.
000150 (2011) Janneke A. Wilschut [Pays-Bas] ; Ewout W. Steyerberg ; Monique E. Van Leerdam ; Iris Lansdorp-Vogelaar ; J Dik F. Habbema ; Marjolein Van BallegooijenHow much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
000163 (2010) Iris Lansdorp-Vogelaar [Pays-Bas] ; Karen M. Kuntz ; Amy B. Knudsen ; Janneke A. Wilschut ; Ann G. Zauber ; Marjolein Van BallegooijenStool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis.
000166 (2010) Amy B. Knudsen ; Iris Lansdorp-Vogelaar ; Carolyn M. Rutter ; James E. Savarino ; Marjolein Van Ballegooijen ; Karen M. Kuntz ; Ann G. ZauberCost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.
000178 (2010) Scott D. Ramsey [États-Unis] ; Janneke Wilschut ; Rob Boer ; Marjolein Van BallegooijenA decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.
000196 (2010) Brenda K. Edwards [États-Unis] ; Elizabeth Ward ; Betsy A. Kohler ; Christie Eheman ; Ann G. Zauber ; Robert N. Anderson ; Ahmedin Jemal ; Maria J. Schymura ; Iris Lansdorp-Vogelaar ; Laura C. Seeff ; Marjolein Van Ballegooijen ; S Luuk Goede ; Lynn A G. RiesAnnual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.
000204 (2009) Iris Lansdorp-Vogelaar [Pays-Bas] ; Marjolein Van Ballegooijen ; Ann G. Zauber ; J Dik F. Habbema ; Ernst J. KuipersEffect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
000212 (2009) Inge M C M. De Kok [Pays-Bas] ; Marjolein Van Ballegooijen ; J Dik F. HabbemaCost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
000215 (2009) Iris Lansdorp-Vogelaar [Pays-Bas] ; Marjolein Van Ballegooijen ; Ann G. Zauber ; Rob Boer ; Janneke Wilschut ; Sidney J. Winawer ; J Dik F. HabbemaIndividualizing colonoscopy screening by sex and race.
000219 (2009) Iris Lansdorp-Vogelaar [Pays-Bas] ; Marjolein Van Ballegooijen ; Rob Boer ; Ann Zauber ; J Dik F. HabbemaA novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials.
000226 (2009) Iris Lansdorp-Vogelaar [Pays-Bas] ; Marjolein Van Ballegooijen ; Ann G. Zauber ; Rob Boer ; Janneke Wilschut ; J Dik F. HabbemaAt what costs will screening with CT colonography be competitive? A cost-effectiveness approach.
000228 (2008) Ann G. Zauber [États-Unis] ; Iris Lansdorp-Vogelaar ; Amy B. Knudsen ; Janneke Wilschut ; Marjolein Van Ballegooijen ; Karen M. KuntzEvaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=MicroSimulV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Marjolein Van Ballegooijen" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Marjolein Van Ballegooijen" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    MicroSimulV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Marjolein Van Ballegooijen
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sun Mar 10 17:35:57 2024. Site generation: Sun Mar 10 17:47:34 2024